What is LinkDoc?
Founded in 2014 and based in Beijing, China, LinkDoc specializes in creating advanced medical data solutions and comprehensive tumor big data platforms. The company's core objective is to provide structured clinical data to China's leading tumor specialist hospitals and comprehensive tertiary hospitals. By leveraging big data analytics, LinkDoc aims to enhance clinical research, improve patient outcomes, and support precision medicine initiatives within the Chinese healthcare system. Their focus on specialized data infrastructure positions them as a critical enabler for medical innovation and data-driven healthcare.
How much funding has LinkDoc raised?
LinkDoc has raised a total of $10M across 1 funding round:
Series A
$10M
Series A (2015): $10M with participation from New Enterprise Associates
Key Investors in LinkDoc
New Enterprise Associates
New Enterprise Associates (NEA) is a globally recognized venture capital firm established in 1977, known for its focus on supporting entrepreneurs across various stages of company development, particularly in technology and healthcare sectors.
What's next for LinkDoc?
With a substantial funding history, LinkDoc is strategically positioned for further expansion and technological advancement. The company's enterprise-level funding context suggests a focus on scaling operations, enhancing its platform capabilities, and potentially broadening its market reach within China's vast healthcare industry. Future developments are likely to involve deeper integration of AI and machine learning for more sophisticated data analysis, as well as forging new partnerships with healthcare institutions to expand its data repository and service offerings. This sustained capital infusion signals a commitment to solidifying its leadership in the medical big data domain.
See full LinkDoc company page
